The improved transgene delivery and efficacy of an Ad.5/3 recombinant virus expressing mda-7/IL-24, has been demonstrated in prostate cancer, glioma, colorectal, and renal cancer [58,92,93,94]. Here, IL24 is linked to central nervous system cancer.